Related Experiment Video
Updated: Jan 26, 2026

Detection of miRNA Targets in High-throughput Using the 3'LIFE Assay
Published on: May 25, 2015
A Day in the Life of a CVAD
Regina E Nailon1, Mark E Rupp, Elizabeth Lyden
1Nebraska Antimicrobial Stewardship Assessment and Promotion Program, Nebraska Infection Control Assessment and Promotion Program, and Nebraska Medicine, Omaha, Nebraska (Dr Nailon); Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska (Dr Rupp); and College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska (Ms Lyden). Regina E. Nailon, PhD, RN, facilitates interprofessional research and meaningful use of data in clinical decision making at Nebraska Medicine. Her primary research focus is aimed at improving health outcomes and the infrastructure necessary for the delivery of safe and appropriate care across the care continuum. Mark E. Rupp, MD, is professor and chief of the Division of Infectious Diseases at the University of Nebraska Medical Center. He is also the medical director of the Department of Infection Control and Epidemiology. Dr Rupp studies device-associated infections, staphylococcal disease, and antimicrobial stewardship. Elizabeth Lyden, MS, is associate director of the Center for Collaboration on Research, Design and Analysis, and an instructor in the Department of Biostatistics at the University of Nebraska Medical Center. She provides consultation, data analysis, and manuscript preparation in multiple departments including infectious diseases.
Abstract:
Patients are increasingly receiving therapy at home via central vascular access devices (CVADs). Limited data exist regarding patients' experiences with outpatient CVADs. This study characterized outpatient CVAD care via 14-day patient diaries. Information included location, frequency, and purpose of CVAD access episodes and who performed CVAD care. Across all patients, 77% of care was provided in the patient's home compared with other sites. Home care was provided via self-care (48%), by a family member/caregiver (25%), or by a nurse (27%). Flushing the device was the most frequent reason for device access (52%). An occlusion rate of 9.57 per 1000 device days was also noted. Further examination of CVAD maintenance and patient/care provider education is warranted.
Related Concept Videos
Half-life of a Reaction
Characteristics of Life
The Angiosperm Life Cycle
The Tree of Life - Bacteria, Archaea, Eukaryotes
Life Histories
Three-Domain System of Life

